# Cost-Effectiveness and Implementation Strategies for Hypertension Management Using Non-Physician Healthcare Workers in Low- and Middle-Income Countries: A Systematic Review

**Authors:** Gabriel Lamkur Shedul, Olutobi Adekunle Sanuade, Emmanuel Iroboudu Okpetu, Molly Beestrum, Dike Bevis Ojji, Lisa R. Hirschhorn, Mark D. Huffman, Dustin D. French

PMC · DOI: 10.5334/gh.1533 · 2026-03-12

## TL;DR

This review finds that non-physician healthcare workers can manage hypertension in low- and middle-income countries at a low cost, but more research is needed.

## Contribution

The study systematically evaluates the cost-effectiveness and implementation strategies of using non-physician workers for hypertension care in LMICs.

## Key findings

- Non-physician healthcare workers achieved cost per mmHg reduction of $2.25 systolic and $2.03 diastolic.
- Cost per controlled patient was $1.48, and ICERs ranged from $0.41 to $14,373.97.
- Training and community engagement were key implementation strategies.

## Abstract

This review assessed the cost-effectiveness and implementation strategies of hypertension management by non-physician healthcare workers (NPHCWs) in low- and middle-income countries (LMICs).

A systematic search (inception–May 2024) included adults ≥18 years managed by NPHCWs LMICs, following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Economic evaluations were assessed using Drummond’s checklist and ROBINS-I.

Seven studies (2002–2022) conducted across eight countries enrolled 96–10,000 participants and included randomized, modeling, observational, and quasi-experimental designs. NPHCWs included pharmacists, community and village health workers, and nurses. Patients’ mean age ranged 58–71 years, with 57–82% female. Outcomes assessed included cost per mmHg reduction ($INT 2.25 systolic, $INT 2.03 diastolic), per controlled patient ($INT 1.48), annual cost ($INT 0.22–232.31), cost per disability-adjusted life year (DALY) averted ($INT 411.39–4709.96), and per quality-adjusted life year (QALY) gained ($INT 1.04–13.30). Incremental cost-effectiveness ratio (ICERs) varied ($INT 0.41–14,373.97). Strategies included NPHCWs training and community engagement/counseling.

Hypertension management by NPHCWs appears cost-effective in LMICs, though more studies are needed for generalizability.

## Full-text entities

- **Diseases:** Hypertension (MESH:D006973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12985814/full.md

---
Source: https://tomesphere.com/paper/PMC12985814